Your browser doesn't support javascript.
loading
Histology of colorectal adenocarcinoma with double somatic mismatch-repair mutations is indistinguishable from those caused by Lynch syndrome.
Hemminger, Jessica A; Pearlman, Rachel; Haraldsdottir, Sigurdis; Knight, Deborah; Jonasson, Jon Gunnlaugur; Pritchard, Colin C; Hampel, Heather; Frankel, Wendy L.
Afiliación
  • Hemminger JA; Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
  • Pearlman R; Department of Internal Medicine, Division of Human Genetics, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
  • Haraldsdottir S; Department of Medicine/Oncology, Stanford University Medical Center, Stanford, CA 94305, USA.
  • Knight D; Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
  • Jonasson JG; Landspitali University Hospital, Reykjavik 101, Iceland.
  • Pritchard CC; Department of Laboratory Medicine, University of Washington, Seattle, WA 98195, USA.
  • Hampel H; Department of Internal Medicine, Division of Human Genetics, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
  • Frankel WL; Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA. Electronic address: wendy.frankel@osumc.edu.
Hum Pathol ; 78: 125-130, 2018 08.
Article en En | MEDLINE | ID: mdl-29723603
Lynch syndrome (LS) is the most common form of hereditary colon cancer. Germline mutations in the mismatch-repair (MMR) genes MLH1, MSH2 (EPCAM), MSH6, and PMS2, followed by a second hit to the remaining allele, lead to cancer development. Universal tumor screening for LS is routinely performed on colon cancer, and screening has identified patients with unexplained MMR deficiency that lack MLH1 methylation and a germline mutation. Tumor sequencing has since identified double somatic (DS) mutations in the MMR gene corresponding with the absent protein in 69% of these patients. We assessed whether histomorphology could distinguish patients with DS mutations from those with LS. Colorectal cancer patients with DS mutations were identified from population-based cohorts from Iceland (2000-2009); Columbus, Ohio (1999-2005); and the state of Ohio (2013-2016). Next-generation sequencing was performed on tumors with unexplained MMR deficiency. Patients with LS from Ohio cohorts were the comparison group. The histologic features associated with MMR deficiency (tumor-infiltrating lymphocytes, Crohn-like reaction, histologic subtype, necrosis) were evaluated. We identified 43 tumors with DS mutations and 48 from patients with LS. There was no significant difference in histologic features between tumors in LS patients and tumors with DS mutations. Because histology of tumors with DS mutations is indistinguishable from those caused by LS, tumor sequencing for evaluation of DS mutations should be considered to help clarify sporadic versus hereditary causes of unexplained MMR deficiency.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Neoplasias Colorrectales Hereditarias sin Poliposis / Neoplasias del Colon / Reparación de la Incompatibilidad de ADN Tipo de estudio: Diagnostic_studies / Screening_studies Límite: Female / Humans / Male Idioma: En Revista: Hum Pathol Asunto de la revista: PATOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Neoplasias Colorrectales Hereditarias sin Poliposis / Neoplasias del Colon / Reparación de la Incompatibilidad de ADN Tipo de estudio: Diagnostic_studies / Screening_studies Límite: Female / Humans / Male Idioma: En Revista: Hum Pathol Asunto de la revista: PATOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos